Related Experiment Video

Updated: Jun 30, 2026

Quantification of Hypopigmentation Activity In Vitro
06:08

Quantification of Hypopigmentation Activity In Vitro

Published on: March 6, 2019

Mechanism of tyrosinase inhibition by deoxyArbutin and its second-generation derivatives

S Chawla1, M A deLong, M O Visscher

  • 1Department of Dermatology, University of Cincinnati College of Medicine, and Skin Sciences Institute, Cincinnati Children's Hospital Medical Center, 231 Albert Sabin Way, Mail Location #0592, Cincinnati, OH 45267-0592, USA.

The British Journal of Dermatology
|September 25, 2008
PubMed
Abstract

Insights

New deoxyArbutin derivatives effectively inhibit melanin production, offering a safer and reversible solution for hyperpigmentation. These compounds show promise as depigmenting agents with reduced toxicity compared to existing treatments.

Area of Science:

  • Biochemistry
  • Dermatology
  • Pharmacology

Background:

  • Hyperpigmentation disorders like age spots and melasma result from increased epidermal melanin.
  • Current depigmentation therapies exhibit limitations including cytotoxicity and poor efficacy.

Purpose of the Study:

  • To investigate novel compounds for skin depigmentation that meet medical requirements.
  • To evaluate deoxyArbutin (dA) and its derivatives as safer and more effective skin-lightening agents.

Main Methods:

  • Assessed the efficacy and reversibility of dA and its derivatives in inhibiting tyrosinase (tyrosine hydroxylase and DOPAoxidase) activities.
  • Conducted in vitro assays using purified mushroom and human tyrosinase.
  • Utilized Lineweaver-Burk reciprocal plot analysis.

Main Results:

  • dA and its second-generation derivatives demonstrated dose-dependent inhibition of tyrosinase activities, reducing melanin synthesis in melanocytes with high cell viability.
  • The depigmenting effects were fully reversible upon compound removal.
  • These compounds were identified as direct, potent competitive inhibitors of tyrosinase, outperforming hydroquinone (HQ) in vitro.

Conclusions:

  • dA and its second-generation derivatives inhibit melanogenesis by targeting the tyrosinase enzyme at a post-translational level.
  • These compounds offer a promising, safe, and effective approach for treating hyperpigmented lesions and skin lightening.

More Related Videos

Methods to Inhibit Bacterial Pyomelanin Production and Determine the Corresponding Increase in Sensitivity to Oxidative Stress11:00

Methods to Inhibit Bacterial Pyomelanin Production and Determine the Corresponding Increase in Sensitivity to Oxidative Stress

Published on: August 31, 2015

Related Concept Videos

Epistasis01:39

Epistasis

In addition to multiple alleles at the same locus influencing traits, numerous genes or alleles at different locations may interact and influence phenotypes in a phenomenon called epistasis. For example, rabbit fur can be black or brown depending on whether the animal is homozygous dominant or heterozygous at a TYRP1 locus. However, if the rabbit is also homozygous recessive at a locus on the tyrosinase gene (TYR), it will have an unshaded coat that appears white, regardless of its TYRP1...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Epistasis Analysis01:09

Epistasis Analysis

Although Mendel chose seven unrelated traits in peas to study gene segregation, most traits involve multiple gene interactions that create a spectrum of phenotypes. When the interaction of various genes or alleles at different locations influences a phenotype, this is called epistasis. Epistasis often involves one gene masking or interfering with the expression of another (antagonistic epistasis). Epistasis often occurs when different genes are part of the same biochemical pathway. The...
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...